Novo Nordisk Second Best in the World at Providing Access to Medicine
Bagsværd, Denmark, November 17, 2014 /3BL Media/ – Today, it was announced that Novo Nordisk ranks second on the 2014 Access to Medicine Index, climbing four places since the 2012 Index. Novo Nordisk’s ranking is a reflection of the company’s inclusion of access to medicine within its core business, including equitable pricing strategies, local capability building and integrating philanthropy with business activities.
In 2013, Novo provided medical treatments for approximately 24.3 million people with diabetes worldwide, showing a 7% increase compared with 2012.
“Today, more than 80% of people with diabetes live in low- and middle-income countries where access to medicine and treatment is simply not adequate for the millions in need,” says Lars Rebien Sørensen, chief executive officer at Novo Nordisk. “Last year, we launched our Strategy for Global Access to Diabetes Care strengthening our already existing efforts to break down barriers that inhibit access to care and help us reach 40 million people living with diabetes by 2020.”
Read More: http://3blmedia.com/News/Novo-Nordisk-Second-Best-World-Providing-Access-Medicine/
© 2014 | 3BL Media/Novo Nordisk | All Rights Reserved